We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Gene Expression Suggests Sexes Evolve Differently

By LabMedica International staff writers
Posted on 18 May 2017
Print article
Image: A recent study found that about 6,500 genes are expressed differently in men and women (Photo courtesy of the Weizmann Institute of Science).
Image: A recent study found that about 6,500 genes are expressed differently in men and women (Photo courtesy of the Weizmann Institute of Science).
A team of molecular geneticists has found that a large number of genes are expressed differently in men and women, which begins to explain why that despite sharing almost identical genomes the two sexes are distinctly dimorphic, with dissimilar disease susceptibilities and mutation rates.

To perform this study, investigators at the Weizmann Institute of Science called upon the resources of the Genotype-Tissue Expression project. The GTEx project was designed to provide to the scientific community a resource with which to study human gene expression and regulation and its relationship to genetic variation. This project collects and analyzes multiple human tissues from donors who are also densely genotyped, to assess genetic variation within their genomes. By analyzing global RNA expression within individual tissues and treating the expression levels of genes as quantitative traits, variations in gene expression that are highly correlated with genetic variation. Correlations between genotype and tissue-specific gene expression levels will help identify regions of the genome that influence whether and how much a gene is expressed. GTEx will help researchers to understand inherited susceptibility to disease and will be a resource database and tissue bank for many studies in the future.

Using information made available by the GTEx project, the Weizmann Institute investigators comprehensively mapped human sex-differential genetic architecture across 53 tissues. By analyzing GTEx RNA-sequencing data from 544 adults, they identified approximately 6,500 genes that were differentially expressed in the reproductive tracts and tissues common to both sexes.

The investigators reported in reported in the February 7, 2017, online edition of the journal BMC Biology that sex-differential genes were related to various biological systems, which suggested new insights into the pathophysiology of diverse human diseases. They also identified a significant association between sex-specific gene transcription and reduced selection efficiency and accumulation of deleterious mutations, which might affect the prevalence of different traits and diseases. Many of the sex-specific genes that also underwent reduced selection efficiency were essential for successful reproduction in men or women. This seeming paradox might partially explain the high incidence of human infertility.

"In many species, females can produce only a limited number of offspring while males can, theoretically, father many more; so the species' survival will depend on more viable females in the population than males," said senior author Dr. Shmuel Pietrokovski, professor of molecular genetics at the Weizmann Institute of Science. "Thus natural selection can be more "lax" with the genes that are only harmful to males. Paradoxically, sex-linked genes are those in which harmful mutations are more likely to be passed down, including those that impair fertility. From this vantage point, men and women undergo different selection pressures and, at least to some extent, human evolution should be viewed as co-evolution. But the study also emphasizes the need for a better understanding of the differences between men and women in the genes that cause disease or respond to treatments."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.